SEHK:2367
SEHK:2367Personal Products

Giant Biogene Holding (SEHK:2367): Assessing Valuation After Launching a 10% Share Buyback Program

Giant Biogene Holding (SEHK:2367) has kicked off a sizeable share repurchase program, with approval to buy back up to 10% of its share capital. This move puts capital allocation firmly in the spotlight for investors. See our latest analysis for Giant Biogene Holding. The buyback comes after a tough stretch, with a 90 day share price return of negative 41.32 percent, but a recent 4.40 percent 7 day share price return around HK$36.06 hints that sentiment may be stabilising rather than sliding...
SEHK:883
SEHK:883Oil and Gas

CNOOC (SEHK:883): Revisiting Valuation After a Recent Share Price Climb

CNOOC (SEHK:883) has quietly outperformed this year, and that kind of steady move often slips under the radar. With the share price still below many valuation estimates, investors are revisiting the long term case. See our latest analysis for CNOOC. The recent climb to around HK$20.8 follows a solid 90 day share price return near 10 percent. At the same time, a far stronger multiyear total shareholder return suggests momentum is still broadly constructive rather than exhausted. If CNOOC has...